Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Ramsay Health Care Ltd

Healthcare AU RHCPA

107.51AUD
-0.04(0.04%)

Last update at 2026-03-11T05:10:00Z

Day Range

107.50107.81
LowHigh

52 Week Range

100.07107.95
LowHigh

Fundamentals

  • Previous Close 107.55
  • Market Cap14446.65M
  • Volume3128
  • P/E Ratio65.76
  • Dividend Yield0.77%
  • EBITDA1659.60M
  • Revenue TTM18618.60M
  • Revenue Per Share TTM80.99
  • Gross Profit TTM 2209.70M
  • Diluted EPS TTM1.63

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 101.80M 384.60M 527.10M 538.50M 741.60M
Minority interest -22.30000M 7.30M -67.40000M -105.20000M 518.10M
Net income 24.00M 888.70M 298.10M 274.00M 449.00M
Selling general administrative 11040.20M 10323.50M 9431.00M 8309.50M 7817.60M
Selling and marketing expenses - - - - -
Gross profit 13171.90M 12344.30M 11515.30M 9974.30M 9339.60M
Reconciled depreciation 1126.30M 1082.10M 989.10M 927.60M 899.40M
Ebit - - 660.30M 460.90M 690.70M
Ebitda - - 1777.40M 1612.90M 1804.90M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 707.70M 992.30M 554.20M 230.60M 174.80M
Other operating expenses - - - - -
Interest expense 335.20M 339.50M 261.20M 146.80M 163.90M
Tax provision 55.50M 121.30M 181.50M 159.30M 230.10M
Interest income -621.80000M -620.00000M 39.90M 36.20M 7.10M
Net interest income -604.40000M -613.00000M -474.30000M -352.80000M -391.00000M
Extraordinary items 0.00000M 618.10M - 8.10M 27.70M
Non recurring - - - - -
Other items - - - - -
Income tax expense - - 181.50M 159.30M 230.10M
Total revenue 17809.00M 16667.20M 14863.00M 13082.10M 12348.30M
Total operating expenses 17101.30M 15674.90M - - -
Cost of revenue 4637.10M 4322.90M 3347.70M 3107.80M 3008.70M
Total other income expense net -164.30000M 164.40M 447.20M 660.70M 957.80M
Discontinued operations - - 19.90M 15.30M 15.30M
Net income from continuing ops 46.30M 263.30M 345.60M 379.20M 511.50M
Net income applicable to common shares 6.80M 872.00M 285.10M 265.00M 439.90M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 22475.50M 20894.00M 21030.20M 19473.30M 19324.60M
Intangible assets 424.90M 395.00M 407.30M 435.20M 467.30M
Earning assets - - - - -
Other current assets 48.80M 42.40M 279.30M 24.50M 1982.40M
Total liab 16766.80M 15366.50M 16207.00M 14947.10M 14773.80M
Total stockholder equity 5023.60M 4897.60M 4154.80M 3933.50M 4032.70M
Deferred long term liab - - - - -
Other current liab - - 180.30M 318.70M 562.80M
Common stock - - 2216.40M 2197.60M 2197.60M
Capital stock 2482.40M 2436.00M 2400.80M 2377.40M 2373.10M
Retained earnings 2328.70M 2500.20M 1786.70M 1708.70M 1750.90M
Other liab - - 997.10M 939.60M 901.60M
Good will 6006.20M 5744.90M 5756.40M 5363.80M 3766.30M
Other assets - - 719.00M 688.40M 622.00M
Cash 784.40M 662.30M 656.10M 314.20M 1004.80M
Cash and equivalents - - - 314.20M 1004.80M
Total current liabilities 4465.60M 4180.30M 3810.40M 3747.60M 3717.20M
Current deferred revenue - - - - -
Net debt 4752.50M 4421.70M 5275.30M 4902.10M 4275.90M
Short term debt - - - 0.00000M 0.00000M
Short long term debt 78.50M 134.10M 69.90M 42.80M 51.70M
Short long term debt total - - - - 10131.80M
Other stockholder equity - - -32.70000M -152.60000M -91.30000M
Property plant equipment - - 10187.20M 9436.00M 8900.10M
Total current assets 4040.30M 3872.80M 3895.80M 3285.50M 5351.40M
Long term investments 110.80M 94.10M 83.60M 338.90M 300.40M
Net tangible assets - - -2261.10000M -2139.50000M -453.10000M
Short term investments - - - - -
Net receivables 2701.50M 2671.90M 2397.60M 2401.90M 1863.40M
Long term debt 5458.40M 4949.90M 5861.50M 5173.50M 5229.00M
Inventory 404.40M 379.40M 388.60M 376.80M 409.40M
Accounts payable 1728.10M 1651.80M 1484.30M 1483.50M 1164.60M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -76.70000M
Accumulated amortization - - - - -
Non currrent assets other 10.40M 10.30M 10.60M 10.70M 10.90M
Deferred long term asset charges - - - - -
Non current assets total 18435.20M 17021.20M 17134.40M 16186.60M 13973.20M
Capital lease obligations 6583.00M 5854.10M 5954.90M 5482.40M 5271.00M
Long term debt total - - - 10301.10M 10131.80M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -765.30000M 159.70M -713.80000M -48.20000M -0.70000M
Change to liabilities - - 102.80M 124.70M 107.10M
Total cashflows from investing activities -765.30000M 159.70M -713.80000M 30.00M -2504.20000M
Net borrowings 93.20M -825.40000M -3.60000M -1037.80000M 735.90M
Total cash from financing activities -631.20000M -1450.10000M -242.40000M -1410.90000M 584.00M
Change to operating activities - - -89.20000M -31.80000M 43.70M
Net income 24.00M 888.70M 298.10M 274.00M 449.00M
Change in cash 122.10M 6.20M 341.90M -690.60000M -498.90000M
Begin period cash flow 37.80M 656.10M 314.20M 1004.80M 1503.70M
End period cash flow 784.40M 662.30M 656.10M 314.20M 1004.80M
Total cash from operating activities 1480.80M 1292.80M 1279.60M 715.50M 1481.20M
Issuance of capital stock - - - - -
Depreciation - - 962.30M 906.90M 884.00M
Other cashflows from investing activities 11.30M 913.50M 19.90M 1972.20M -1916.60000M
Dividends paid -161.60000M -134.90000M 218.70M 351.90M 115.30M
Change to inventory - - -14.20000M 28.20M -11.40000M
Change to account receivables - - 118.20M -664.80000M -103.90000M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities -54.00000M -39.30000M -20.10000M -21.20000M -36.60000M
Change to netincome - - -32.20000M 72.70M 67.60M
Capital expenditures 776.60M 753.80M 720.90M 708.50M 628.90M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 58.70M - 4.20M 305.90M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow 704.20M 539.00M 558.70M 7.00M 852.30M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
RHCPA
Ramsay Health Care Ltd		 -0.04 0.04% 107.51 65.76 - 0.78 -
RHC
Ramsay Health Care Ltd		 -0.26 0.61% 42.21 34.92 26.25 0.55 1.95 1.15 11.02
SNZ
Summerset Group Holdings Ltd		 - -% 8.50 9.77 5.25 5.90 0.76 12.35 14.90
REG
Regis Healthcare Ltd		 0.08 1.20% 6.77 56.08 28.49 1.61 324.34 3.52 16.69
OCA
Oceania Healthcare Ltd		 -0.015 2.33% 0.63 11.42 - 1.92 0.51 4.60 12.95

Reports Covered

Stock Research & News

View All

Profile

Ramsay Health Care Limited owns and operates hospitals in Australia and internationally. It offers health care services to public and private patients. The company was founded in 1964 and is based in Sydney, Australia.

Ramsay Health Care Ltd

126 Phillip Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Craig Ralph McNally CEO, MD & Exec. Director 1961
Mr. Martyn J. Roberts Group Chief Financial Officer 1968
Ms. Kelly Hibbins Group Head of Investor Relations NA
Ms. Henrietta Rowe BECON, L.L.B. Group Gen. Counsel & Company Sec. NA
Ms. Colleen Harris Group Chief People Officer 1969
Mr. Andrew Wearne Global Chief Audit Exec. NA
Dr. Andrew Jones Group Chief Growth Officer 1974
Sir Edward Byrne AC, DSc, FMEDSCI, FRACP, FRCP, FTSE, M.D., MBA Group Chief Medical Officer 1952
Mr. Kah Peng Hong Group Chief Exec. Officer of Ramsay Sime Darby Health Care 1973
Doug Meagher CFO of Ramsay Australia NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.